Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Colorcon
McKinsey
Express Scripts
Mallinckrodt

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Laninamivir

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Laninamivir: Sponsors, patents, clinical trial progress

Laninamivir is an investigational drug.

There have been 4 clinical trials for Laninamivir. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2013.

The most common disease conditions in clinical trials are Influenza, Human, Asthma, and [disabled in preview]. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Department of Health and Human Services, and National Institute of Allergy and Infectious Diseases (NIAID).

There are three US patents protecting this investigational drug and fifty international patents.

Recent Clinical Trials for Laninamivir
TitleSponsorPhase
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaDepartment of Health and Human ServicesPhase 1/Phase 2
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaBiota Scientific Management Pty LtdPhase 1/Phase 2
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic AsthmaDepartment of Health and Human ServicesPhase 1

See all Laninamivir clinical trials

Clinical Trial Summary for Laninamivir

Top disease conditions for Laninamivir
Top clinical trial sponsors for Laninamivir

See all Laninamivir clinical trials

US Patents for Laninamivir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Laninamivir   Start Trial Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications Pondera Biotechnologies, LLC (Pownal, ME)   Start Trial
Laninamivir   Start Trial Method for manufacturing neuraminic acid derivatives Daiichi Sankyo Company, Limited (Tokyo, JP)   Start Trial
Laninamivir   Start Trial Method for manufacturing neuraminic acid derivatives Daiichi Sankyo Company, Limited (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Laninamivir

Drugname Country Document Number Estimated Expiration Related US Patent
Laninamivir Canada 2785056 2029-12-22   Start Trial
Laninamivir World Intellectual Property Organization (WIPO) 2011087755 2029-12-22   Start Trial
Laninamivir Brazil PI0809601 2027-04-11   Start Trial
Laninamivir Canada 2683065 2027-04-11   Start Trial
Laninamivir Canada 2783587 2027-04-11   Start Trial
Laninamivir Canada 2783620 2027-04-11   Start Trial
Laninamivir Canada 2783688 2027-04-11   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
AstraZeneca
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.